285 related articles for article (PubMed ID: 26655128)
1. The new era of hepatitis C virus therapy.
Al-Judaibi B
Saudi J Gastroenterol; 2015; 21(6):345-54. PubMed ID: 26655128
[TBL] [Abstract][Full Text] [Related]
2. Paediatric hepatitis C virus infection and its treatment: Present, past, and future.
El-Shabrawi M; Hassanin F
Arab J Gastroenterol; 2019 Sep; 20(3):163-174. PubMed ID: 31585703
[TBL] [Abstract][Full Text] [Related]
3. Direct-acting antivirals for chronic hepatitis C.
Jakobsen JC; Nielsen EE; Feinberg J; Katakam KK; Fobian K; Hauser G; Poropat G; Djurisic S; Weiss KH; Bjelakovic M; Bjelakovic G; Klingenberg SL; Liu JP; Nikolova D; Koretz RL; Gluud C
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD012143. PubMed ID: 28922704
[TBL] [Abstract][Full Text] [Related]
4. Direct-acting antivirals for chronic hepatitis C.
Jakobsen JC; Nielsen EE; Feinberg J; Katakam KK; Fobian K; Hauser G; Poropat G; Djurisic S; Weiss KH; Bjelakovic M; Bjelakovic G; Klingenberg SL; Liu JP; Nikolova D; Koretz RL; Gluud C
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD012143. PubMed ID: 28585310
[TBL] [Abstract][Full Text] [Related]
5. Direct-Acting Antiviral Agents for Patients With Hepatitis C Virus Genotype 1 Infection Are Cost-Saving.
Chhatwal J; He T; Hur C; Lopez-Olivo MA
Clin Gastroenterol Hepatol; 2017 Jun; 15(6):827-837.e8. PubMed ID: 27650326
[TBL] [Abstract][Full Text] [Related]
6. Cost effectiveness of direct-acting antiviral therapy for treatment-naive patients with chronic HCV genotype 1 infection in the veterans health administration.
Chan K; Lai MN; Groessl EJ; Hanchate AD; Wong JB; Clark JA; Asch SM; Gifford AL; Ho SB
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1503-10. PubMed ID: 23707354
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hepatitis C: a systematic review.
Kohli A; Shaffer A; Sherman A; Kottilil S
JAMA; 2014 Aug; 312(6):631-40. PubMed ID: 25117132
[TBL] [Abstract][Full Text] [Related]
8. [Chronic hepatitis C infection--eradication of the virus].
Ben Ari Z
Harefuah; 2014 Jul; 153(7):392-3, 433. PubMed ID: 25189028
[TBL] [Abstract][Full Text] [Related]
9. Regimens for the Hepatitis C Treatment-Naive Patient.
Ayoub WS; Tran TT
Clin Liver Dis; 2015 Nov; 19(4):619-27, v. PubMed ID: 26466651
[TBL] [Abstract][Full Text] [Related]
10. Antiviral therapy with nucleotide polymerase inhibitors for chronic hepatitis C.
Kumar S; Jacobson IM
J Hepatol; 2014 Nov; 61(1 Suppl):S91-7. PubMed ID: 25443349
[TBL] [Abstract][Full Text] [Related]
11. Phase III results of Boceprevir in treatment naïve patients with chronic hepatitis C genotype 1.
Manns MP; Markova AA; Calle Serrano B; Cornberg M
Liver Int; 2012 Feb; 32 Suppl 1():27-31. PubMed ID: 22212568
[TBL] [Abstract][Full Text] [Related]
12. Serine protease inhibitors as anti-hepatitis C virus agents.
Reiser M; Timm J
Expert Rev Anti Infect Ther; 2009 Jun; 7(5):537-47. PubMed ID: 19485794
[TBL] [Abstract][Full Text] [Related]
13. Consensus on management of hepatitis C virus infection in resource-limited Ukraine and Commonwealth of Independent States regions.
Colombo MG; Musabaev EI; Ismailov UY; Zaytsev IA; Nersesov AV; Anastasiy IA; Karpov IA; Golubovska OA; Kaliaskarova KS; Ac R; Hadigal S
World J Gastroenterol; 2019 Aug; 25(29):3897-3919. PubMed ID: 31413526
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus markers in infection by hepatitis C virus: In the era of directly acting antivirals.
Coppola N; Pisaturo M; Zampino R; Macera M; Sagnelli C; Sagnelli E
World J Gastroenterol; 2015 Oct; 21(38):10749-59. PubMed ID: 26478667
[TBL] [Abstract][Full Text] [Related]
15. Systematic review: economic evaluations of HCV screening in the direct-acting antivirals era.
Cortesi PA; Barca R; Giudicatti G; Mossini S; Ciaccio A; Iannazzo S; Micale M; Cesana G; Mantovani LG
Aliment Pharmacol Ther; 2019 May; 49(9):1126-1133. PubMed ID: 30843268
[TBL] [Abstract][Full Text] [Related]
16. Peginterferon alfa and ribavirin for chronic hepatitis C in patients eligible for shortened treatment, re-treatment or in HCV/HIV co-infection: a systematic review and economic evaluation.
Hartwell D; Jones J; Baxter L; Shepherd J
Health Technol Assess; 2011 Apr; 15(17):i-xii, 1-210. PubMed ID: 21473834
[TBL] [Abstract][Full Text] [Related]
17. New treatments for chronic hepatitis C virus infection.
Corouge M; Pol S
Med Mal Infect; 2011 Nov; 41(11):579-87. PubMed ID: 21764234
[TBL] [Abstract][Full Text] [Related]
18. Cost-Utility of All-Oral Direct-Acting Antiviral Regimens for the Treatment of Genotype 1 Chronic Hepatitis C Virus-Infected Patients in Hong Kong.
Yuen MF; Liu SH; Seto WK; Mak LY; Corman SL; Hsu DC; Lee MYK; Khan TK; Puenpatom A
Dig Dis Sci; 2021 Apr; 66(4):1315-1326. PubMed ID: 32385703
[TBL] [Abstract][Full Text] [Related]
19. Does antiviral therapy reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis C?
Michielsen P; Ho E; Francque S
Minerva Gastroenterol Dietol; 2012 Mar; 58(1):65-79. PubMed ID: 22419005
[TBL] [Abstract][Full Text] [Related]
20. Mathematical Modeling of Hepatitis C Prevalence Reduction with Antiviral Treatment Scale-Up in Persons Who Inject Drugs in Metropolitan Chicago.
Echevarria D; Gutfraind A; Boodram B; Major M; Del Valle S; Cotler SJ; Dahari H
PLoS One; 2015; 10(8):e0135901. PubMed ID: 26295805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
